Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insight into human allogeneic CAR-T therapy: an open-access dataset.

Drug discovery today·2026
Same author

Development and Implementation of a Hinderance-based In Vitro Model for Porous Membranes.

The AAPS journal·2026
Same author

Relating plaque psoriasis barrier function changes with the underlying skin morphology and physiology.

Journal of pharmaceutical sciences·2026
Same author

Dataset of xenobiotics human renal clearance values.

Database : the journal of biological databases and curation·2026
Same author

Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability.

The AAPS journal·2026
Same author

Exploring Tafamidis Effects Through PBPK-QSP Modelling.

Pharmaceutics·2026

Related Experiment Video

Updated: Jun 20, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

hERG in vitro interchange factors--development and verification.

Barbara Wiśniowska1, Sebastian Polak

  • 1Toxicology Department, Faculty of Pharmacy, Medical College, Jagiellonian University, Poland.

Toxicology Mechanisms and Methods
|September 26, 2009
PubMed
Summary

Develop extrapolation factors for comparing hERG IC50 values across different experimental systems and temperatures. These factors improve drug development by enabling flexible experimental choices and reliable cardiotoxic risk assessment.

More Related Videos

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells
08:21

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells

Published on: March 16, 2017

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology
09:12

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology

Published on: July 28, 2023

Related Experiment Videos

Last Updated: Jun 20, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
09:26

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells
08:21

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells

Published on: March 16, 2017

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology
09:12

In Vitro Model of Fetal Human Vessel On-chip to Study Developmental Mechanobiology

Published on: July 28, 2023

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Biophysics

Background:

  • hERG channel IC50 values vary significantly across different in vitro experimental conditions and systems.
  • This variability complicates drug development and cardiotoxic risk assessment.
  • A standardized method for comparing these values is needed.

Purpose of the Study:

  • To develop extrapolation factors for comparing hERG IC50 values across different cell systems (HEK, CHO, XO) and temperatures (room, physiological).
  • To enable more flexible experimental design in drug development without compromising data integrity.
  • To enhance the reliability of cardiotoxic risk evaluation and in silico modeling.

Main Methods:

  • Analysis of collected hERG IC50 data from various in vitro systems and temperatures.
  • Development of extrapolation factors based on the analyzed data.
  • Verification of the developed factors by comparing them with native HEK IC50 values at physiological temperature.

Main Results:

  • Extrapolation factors were successfully developed for inter-system and inter-temperature IC50 value comparisons.
  • Low error estimates confirmed the good predictive value of the developed factors.
  • The factors demonstrated efficiency when verified against native HEK IC50 values.

Conclusions:

  • The developed extrapolation factors provide a reliable method for comparing hERG IC50 data across diverse experimental conditions.
  • These factors support flexible experimental model selection and ambient temperature testing in drug development.
  • The factors facilitate data comparison, enabling more accurate cardiotoxic risk assessment and in silico modeling for drug candidates.